Literature DB >> 10823031

A unified concept of idiopathic orofacial pain: clinical features.

A Woda1, P Pionchon.   

Abstract

The main features of atypical facial pain, stomatodynia, atypical odontalgia, and masticatory muscle and temporomandibular joint (TMJ) disorders are compared in this article, which included a search of articles indexed in MEDLINE. The fact that their terminology has been the subject of many debates can be considered a consequence of taxonomic difficulties and uncertainties. Epidemiologic studies indicate marked female predominance for all types of idiopathic orofacial pain. There is also a difference in the age of maximal prevalence between masticatory muscle and TMJ disorders and the other entities. The clinical presentations display several symptoms in common. Pain is oral, perioral, or facial and does not follow a nervous pathway. It has been present for the last 4 to 6 months or has returned periodically in the same form over a period of several months or years. The pain is continuous, has no major paroxysmal character, and is present throughout all or part of the day. It is generally absent during sleep. Clinical, radiographic, or laboratory examination does not reveal any obvious organic cause of pain. There is also a frequent presence of certain psychologic factors, personality traits, or life events. Based on these shared characteristics, a unified concept is proposed. Each of these entities belongs to a group of idiopathic orofacial pain and could be expressed in either the jaws, the buccal mucosa, the teeth, the masticatory muscles, or the TMJ.

Entities:  

Mesh:

Year:  1999        PMID: 10823031

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  18 in total

1.  Atypical orofacial pain disorders: a study of diagnostic subtypes.

Authors:  J R Fricton
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Clinical and experimental aspects of temporomandibular disorders.

Authors:  P Svensson; L Arendt-Nielson
Journal:  Curr Rev Pain       Date:  2000

3.  Differential changes in gingival somatosensory sensitivity after painful electrical tooth stimulation.

Authors:  Lene Baad-Hansen; Shengyi Lu; Pentti Kemppainen; Thomas List; Zhenting Zhang; Peter Svensson
Journal:  Exp Brain Res       Date:  2015-01-08       Impact factor: 1.972

Review 4.  Chronic orofacial pain.

Authors:  Sowmya Ananthan; Rafael Benoliel
Journal:  J Neural Transm (Vienna)       Date:  2020-03-04       Impact factor: 3.575

Review 5.  Interventions for treating burning mouth syndrome.

Authors:  Roddy McMillan; Heli Forssell; John Ag Buchanan; Anne-Marie Glenny; Jo C Weldon; Joanna M Zakrzewska
Journal:  Cochrane Database Syst Rev       Date:  2016-11-18

6.  Classifying orofacial pains: a new proposal of taxonomy based on ontology.

Authors:  D R Nixdorf; M T Drangsholt; D A Ettlin; C Gaul; R De Leeuw; P Svensson; J M Zakrzewska; A De Laat; W Ceusters
Journal:  J Oral Rehabil       Date:  2011-08-18       Impact factor: 3.837

7.  Regulation of the trigeminal NR1 subunit expression induced by inflammation of the temporomandibular joint region in rats.

Authors:  Shuxing Wang; Grewo Lim; Ji Mao; Backil Sung; Jianren Mao
Journal:  Pain       Date:  2008-12-05       Impact factor: 6.961

8.  Blink reflexes in patients with atypical odontalgia and matched healthy controls.

Authors:  Lene Baad-Hansen; Thomas List; Holger Kaube; Troels S Jensen; Peter Svensson
Journal:  Exp Brain Res       Date:  2006-02-18       Impact factor: 1.972

9.  Intraoral somatosensory abnormalities in patients with atypical odontalgia--a controlled multicenter quantitative sensory testing study.

Authors:  Lene Baad-Hansen; Maria Pigg; Susanne Eímasry Ivanovic; Hanan Faris; Thomas List; Mark Drangsholt; Peter Svensson
Journal:  Pain       Date:  2013-04-06       Impact factor: 6.961

10.  Evaluation of a magnetic resonance-compatible dentoalveolar tactile stimulus device.

Authors:  Estephan J Moana-Filho; Donald R Nixdorf; David A Bereiter; Mike T John; Noam Harel
Journal:  BMC Neurosci       Date:  2010-10-28       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.